This page reprints a manufacturer label. Everything below in quotation marks is copied from BISMUSAL SUSPENSION, published by FDA and retrieved on 2026-09-16. Nothing has been added, reworded or left out of the sections shown. It is the manufacturer’s label, reproduced as published.
This page reprints the FDA label for BISMUSAL SUSPENSION by Aspen Veterinary Resources, Ltd, a bismuth product labelled for dogs and cats. The sections below are copied from that label without change, with the set id and the date it was retrieved from DailyMed. 4 other stored labels carry the same active ingredient and are listed at the end.
The label
Product: BISMUSAL SUSPENSION. Manufacturer: Aspen Veterinary Resources, Ltd. FDA Structured Product Label set id 978286be-3707-48c3-a1ee-fa6517bfdf50. Label effective 2017-10-11. Retrieved 2026-09-16 from the DailyMed animal label release, and readable on DailyMed.
Indications
A palatable oral suspension for use as an aid in the control of simple diarrhea in cattle, horses, and dogs.
Dosage and Administration
Administer orally after the first sign of diarrhea and after each loose bowel movement or as needed. Dogs - 1 to 3 tablespoons Calves - 3 to 4 ounces Foals - 3 to 4 ounces Cattle and Horses - 6-10 fl. oz. This product may cause stools to darken. If diarrhea persists after using this product for 2 days, contact veterinarian. COMPOSITION ACTIVE INGREDIENT Bismuth Subsalicylate .......................... 0.52 g/oz INACTIVE INGREDIENTS Guar Gum, Dextrose Monohydrate, Disodium Edetate, Methyl Paraben, Methyl Salicylate, Propyl Paraben, Sodium Carbonate, Sorbitol 70%, FD&C Red #40. Store at room temrpeature not above 37°C (98.6°F) Protect from freezing. FOR ORAL USE ONLY SHAKE WELL BEFORE USING. TAKE TIME OBSERVE LABEL DIRECTIONS AS Bismusal Suspension
Contraindications
Not recommended for use in cats.
Other labels for this ingredient
These labels are also stored for the same active ingredient. They are not identical to the one reprinted above, and each is listed by product and set id rather than merged with it.
- Corrective Suspension Anti-Diarrheal Suspension, Phoenix Pharmaceutical Inc./ Clipper Distributing, Inc.. Set id 3d1c67bf-21ef-44f9-b0b3-2e8be0c5fd7d.
- BISMUTH SUSPENSION, MWI Veterinary Supply, Inc.. Set id c17b5fe0-c6db-4eaa-8350-8a448752fc2e.
- VEDCO BISMU-KOTE, VEDCO. Set id 905a863b-8971-46c1-bc79-5ae7bd9fa904.
- ASPEN VETERINARY BISMUSOL, ASPEN VETERINARY. Set id 10200bcc-068d-4723-b146-f950e9b99fcd.
FDA adverse event reports
The FDA Center for Veterinary Medicine publishes the adverse event reports it receives through openFDA. The counts below are the reports naming bismuth as an active ingredient for each species this label names, as returned on 2026-09-16, coded by the VeDDRA reaction term the reporter chose. Reactions are counted per report, so one report can appear under several terms.
These are counts, not rates. Reporting is voluntary, the number of animals treated is not known, and a widely used product accumulates reports for that reason alone. A report records that an event followed a dose; it does not establish that the product caused it. The counts say nothing about how one product compares with another.
Dogs: 85 reports
| VeDDRA reaction term | Reports |
|---|---|
| Vomiting | 26 |
| Diarrhoea | 22 |
| Lethargy (see also Central nervous system depression in 'Neurological') | 15 |
| Anorexia | 10 |
| Death | 9 |
| Dehydration | 8 |
| Death by euthanasia | 7 |
| Elevated alanine aminotransferase (ALT) | 7 |
| Not eating | 7 |
| Ataxia | 6 |
| Bloody diarrhoea | 6 |
| Emesis | 6 |
| Hypoalbuminaemia | 6 |
| Other abnormal test result NOS | 6 |
| Decreased appetite | 5 |
Outcome as recorded by the reporter: Ongoing 21; Recovered/Normal 18; Outcome Unknown 12; Died 11; Euthanized 6.
Queries: reports, reactions, outcomes. Dataset: openFDA Animal and Veterinary Adverse Event Reports.
Cats: 10 reports
| VeDDRA reaction term | Reports |
|---|---|
| Ataxia | 3 |
| Diarrhoea | 2 |
| Elevated total bilirubin | 2 |
| Head tilt - ear disorder | 2 |
| Renal failure | 2 |
| Administration error NOS | 1 |
| Blood in faeces | 1 |
| Brain tumour | 1 |
| Central nervous system disorder NOS | 1 |
| Death | 1 |
| Death by euthanasia | 1 |
| Decreased appetite | 1 |
| Elevated alanine aminotransferase (ALT) | 1 |
| Emesis (multiple) | 1 |
| Hyperglycaemia | 1 |
Outcome as recorded by the reporter: Outcome Unknown 2; Euthanized 1; Recovered/Normal 1.
Queries: reports, reactions, outcomes. Dataset: openFDA Animal and Veterinary Adverse Event Reports.
Sources
- BISMUSAL SUSPENSIONFDA · retrieved 2026-09-16
“Administer orally after the first sign of diarrhea and after each loose bowel movement or as needed.” (Dosage and Administration)
- openFDA Animal and Veterinary Adverse Event ReportsFDA · retrieved 2026-09-16
Related
From Glarda
The note drafted from the consult, with the reference you just read sitting beside it in the shape your record already expects.